Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial
Stephen J. Thomas
◽
John L. Perez
◽
Stephen P. Lockhart
◽
Subramanian Hariharan
◽
Nicholas Kitchin
◽
...
2017 ◽
Vol 146
(3)
◽
pp. 531-537
◽
Martee L. Hensley
◽
Shreyaskumar R. Patel
◽
Margaret von Mehren
◽
Kristen Ganjoo
◽
Robin L. Jones
◽
...
2016 ◽
Vol 74
(5)
◽
pp. AB257
2015 ◽
Vol 20
(8)
◽
pp. 1222-1228
◽
Sang Haak Lee
◽
Jongmin Lee
◽
Kwang Ha Yoo
◽
Soo‐Taek Uh
◽
Myung Jae Park
◽
...
2012 ◽
Vol 7
(3)
◽
pp. 567-573
◽
Chandra Prakash Belani
◽
Yi-Long Wu
◽
Yuh-Min Chen
◽
Joo-Hang Kim
◽
Sung-Hyun Yang
◽
...
2021 ◽
Vol 116
(1)
◽
pp. S545-S546
Herbert L. Bonkovsky
◽
Paolo Ventura
◽
Laurent Gouya
◽
Paula Aguilera Peiró
◽
D. Montgomery Bissell
◽
...
2016 ◽
Vol 68
(6)
◽
pp. 744-752
◽
Paul Emery
◽
Roy M. Fleischmann
◽
Ingrid Strusberg
◽
Patrick Durez
◽
Peter Nash
◽
...
Close
Export Citation Format
Close
Share Document
Close